Concepedia

Kevin A. Abney

KA

Statistics

Publications

5

Citations

179

H-Index

5

Active since

2016

Affiliations

University of South Alabama(Current)

Dartmouth College

Alabama College of Osteopathic Medicine

Kevin A. Abney is an author at University of South Alabama specializing in threonine protein phosphatases, pharmacology, and life sciences.

Publications per year

2016–2020

5

Publications

5

The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C

Brandon D’Arcy, Mark R. Swingle, Cinta M. Papke et al. · Molecular Cancer Therapeutics · 2019 · 68 citations

, , +11

PP1:Tautomycetin Complex Reveals a Path toward the Development of PP1-Specific Inhibitors

M.S. Choy, Mark R. Swingle, Brandon D’Arcy et al. · Journal of the American Chemical Society · 2017 · 56 citations · Full text

, , +13

Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C

Debasish Chattopadhyay, Mark R. Swingle, E. Alan Salter et al. · Biochemical Pharmacology · 2016 · 29 citations · Full text

, , +12

S100A6 is a positive regulator of PPP5C‐FKBP51‐dependent regulation of endothelial calcium signaling

Barnita Haldar, Caleb L. Hamilton, Viktoriya Solodushko et al. · The FASEB Journal · 2020 · 15 citations · Full text

, , +11

Serine/threonine phosphatase 5 (PP5C/PPP5C) regulates the ISOC channel through a PP5C‐FKBP51 axis

Caleb L. Hamilton, Kevin A. Abney, Audrey A. Vasauskas et al. · Pulmonary Circulation · 2017 · 11 citations · Full text

, , +14

1–5 of 5